369 related articles for article (PubMed ID: 32762714)
1. The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma.
Choudhury SR; Ashby C; Tytarenko R; Bauer M; Wang Y; Deshpande S; Den J; Schinke C; Zangari M; Thanendrarajan S; Davies FE; van Rhee F; Morgan GJ; Walker BA
J Hematol Oncol; 2020 Aug; 13(1):108. PubMed ID: 32762714
[TBL] [Abstract][Full Text] [Related]
2. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
[TBL] [Abstract][Full Text] [Related]
3. Chromatin-based, in cis and in trans regulatory rewiring underpins distinct oncogenic transcriptomes in multiple myeloma.
Alvarez-Benayas J; Trasanidis N; Katsarou A; Ponnusamy K; Chaidos A; May PC; Xiao X; Bua M; Atta M; Roberts IAG; Auner HW; Hatjiharissi E; Papaioannou M; Caputo VS; Sudbery IM; Karadimitris A
Nat Commun; 2021 Sep; 12(1):5450. PubMed ID: 34521827
[TBL] [Abstract][Full Text] [Related]
4. A new multiple myeloma cell line, MEF-1, possesses cyclin D1 overexpression and the p53 mutation.
Yufu Y; Goto T; Choi I; Uike N; Kozuru M; Ohshima K; Taniguchi T; Motokura T; Yatabe Y; Nakamura S
Cancer; 1999 Apr; 85(8):1750-7. PubMed ID: 10223569
[TBL] [Abstract][Full Text] [Related]
5. Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers.
Agirre X; Castellano G; Pascual M; Heath S; Kulis M; Segura V; Bergmann A; Esteve A; Merkel A; Raineri E; Agueda L; Blanc J; Richardson D; Clarke L; Datta A; Russiñol N; Queirós AC; Beekman R; Rodríguez-Madoz JR; San José-Enériz E; Fang F; Gutiérrez NC; García-Verdugo JM; Robson MI; Schirmer EC; Guruceaga E; Martens JH; Gut M; Calasanz MJ; Flicek P; Siebert R; Campo E; Miguel JF; Melnick A; Stunnenberg HG; Gut IG; Prosper F; Martín-Subero JI
Genome Res; 2015 Apr; 25(4):478-87. PubMed ID: 25644835
[TBL] [Abstract][Full Text] [Related]
6. DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma.
Alberge JB; Magrangeas F; Wagner M; Denié S; Guérin-Charbonnel C; Campion L; Attal M; Avet-Loiseau H; Carell T; Moreau P; Minvielle S; Sérandour AA
Clin Epigenetics; 2020 Nov; 12(1):163. PubMed ID: 33138842
[TBL] [Abstract][Full Text] [Related]
7. Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses.
Fabris S; Agnelli L; Mattioli M; Baldini L; Ronchetti D; Morabito F; Verdelli D; Nobili L; Intini D; Callea V; Stelitano C; Lombardi L; Neri A
Genes Chromosomes Cancer; 2005 Feb; 42(2):117-27. PubMed ID: 15543617
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation regulates discrimination of enhancers from promoters through a H3K4me1-H3K4me3 seesaw mechanism.
Sharifi-Zarchi A; Gerovska D; Adachi K; Totonchi M; Pezeshk H; Taft RJ; Schöler HR; Chitsaz H; Sadeghi M; Baharvand H; Araúzo-Bravo MJ
BMC Genomics; 2017 Dec; 18(1):964. PubMed ID: 29233090
[TBL] [Abstract][Full Text] [Related]
9. Post-transcriptional Modifications Contribute to the Upregulation of Cyclin D2 in Multiple Myeloma.
Misiewicz-Krzeminska I; Sarasquete ME; Vicente-Dueñas C; Krzeminski P; Wiktorska K; Corchete LA; Quwaider D; Rojas EA; Corral R; Martín AA; Escalante F; Bárez A; García JL; Sánchez-García I; García-Sanz R; San Miguel JF; Gutiérrez NC
Clin Cancer Res; 2016 Jan; 22(1):207-17. PubMed ID: 26341922
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive characterization of the epigenetic landscape in Multiple Myeloma.
Alaterre E; Ovejero S; Herviou L; de Boussac H; Papadopoulos G; Kulis M; Boireau S; Robert N; Requirand G; Bruyer A; Cartron G; Vincent L; Martinez AM; Martin-Subero JI; Cavalli G; Moreaux J
Theranostics; 2022; 12(4):1715-1729. PubMed ID: 35198065
[No Abstract] [Full Text] [Related]
11. Occurrence of dysregulated oncogenes in primary plasma cells representing consecutive stages of myeloma pathogenesis: indications for different disease entities.
Rasmussen T; Theilgaard-Mönch K; Hudlebusch HR; Lodahl M; Johnsen HE; Dahl IM
Br J Haematol; 2003 Oct; 123(2):253-62. PubMed ID: 14531906
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 gene activation in human myeloma cells is independent of DNA hypomethylation or histone hyperacetylation.
Krieger S; Grunau C; Sabbah M; Sola B
Exp Hematol; 2005 Jun; 33(6):652-9. PubMed ID: 15911089
[TBL] [Abstract][Full Text] [Related]
13. The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts.
Chesi M; Nardini E; Lim RS; Smith KD; Kuehl WM; Bergsagel PL
Blood; 1998 Nov; 92(9):3025-34. PubMed ID: 9787135
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 activation in B-cell malignancy: association with changes in histone acetylation, DNA methylation, and RNA polymerase II binding to both promoter and distal sequences.
Liu H; Wang J; Epner EM
Blood; 2004 Oct; 104(8):2505-13. PubMed ID: 15226187
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer's disease.
Watson CT; Roussos P; Garg P; Ho DJ; Azam N; Katsel PL; Haroutunian V; Sharp AJ
Genome Med; 2016 Jan; 8(1):5. PubMed ID: 26803900
[TBL] [Abstract][Full Text] [Related]
16. Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors.
Avet-Loiseau H; Gerson F; Magrangeas F; Minvielle S; Harousseau JL; Bataille R;
Blood; 2001 Nov; 98(10):3082-6. PubMed ID: 11698294
[TBL] [Abstract][Full Text] [Related]
17. Cord blood DNA methylome in newborns later diagnosed with autism spectrum disorder reflects early dysregulation of neurodevelopmental and X-linked genes.
Mordaunt CE; Jianu JM; Laufer BI; Zhu Y; Hwang H; Dunaway KW; Bakulski KM; Feinberg JI; Volk HE; Lyall K; Croen LA; Newschaffer CJ; Ozonoff S; Hertz-Picciotto I; Fallin MD; Schmidt RJ; LaSalle JM
Genome Med; 2020 Oct; 12(1):88. PubMed ID: 33054850
[TBL] [Abstract][Full Text] [Related]
18. The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells.
Martinez-Garcia E; Popovic R; Min DJ; Sweet SM; Thomas PM; Zamdborg L; Heffner A; Will C; Lamy L; Staudt LM; Levens DL; Kelleher NL; Licht JD
Blood; 2011 Jan; 117(1):211-20. PubMed ID: 20974671
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of DNA methylation profiling and gene expression profiling identifies novel markers in lung cancer in Xuanwei, China.
Wang J; Duan Y; Meng QH; Gong R; Guo C; Zhao Y; Zhang Y
PLoS One; 2018; 13(10):e0203155. PubMed ID: 30286088
[TBL] [Abstract][Full Text] [Related]
20. Impact of mutations in DNA methylation modification genes on genome-wide methylation landscapes and downstream gene activations in pan-cancer.
Lee CJ; Ahn H; Jeong D; Pak M; Moon JH; Kim S
BMC Med Genomics; 2020 Feb; 13(Suppl 3):27. PubMed ID: 32093698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
